Re-irradiation

RADIATION7 trials

Conditions

Astrocytoma of BrainAstrocytoma, MalignantBrain Tumor, PediatricDiffuse GliomaDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-MutantGlioblastomaGlioblastoma Multiforme

Phase 1

REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma

TerminatedNCT03690869

Regeneron PharmaceuticalsDiffuse Intrinsic Pontine Glioma, High Grade Glioma, Refractory Central Nervous System Tumor +3

Start: 2018-09-24End: 2023-05-10Updated: 2025-04-08

Phase 2

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

CompletedNCT03661723

Dana-Farber Cancer InstituteGlioblastoma

Start: 2018-09-28End: 2024-08-01Updated: 2024-09-19

Unknown Phase

Re-Irradiation of Progressive or Recurrent DIPG

CompletedNCT03126266

University of CalgaryRecurrent or Progressive Diffuse Intrinsic Pontine Glioma

Start: 2017-04-15End: 2024-11-25Updated: 2024-12-05

DAHANCA 37. Re-irradiation With Proton Radiotherapy

NCT03981068

Danish Head and Neck Cancer GroupHead and Neck Neoplasms

Start: 2019-09-01End: 2025-08-30Target: 20Updated: 2020-09-25

High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis

RecruitingNCT05301101

Medical College of WisconsinSolid Tumor

Start: 2022-06-13End: 2028-07-01Target: 120Updated: 2026-06-30

RE-irradiation of Diffuse MIdline Glioma paTients

Not yet recruitingNCT06093165

Rigshospitalet, DenmarkBrain Tumor, Pediatric, Diffuse Glioma, Diffuse Intrinsic Pontine Glioma +3

Start: 2023-10-31End: 2029-11-30Target: 59Updated: 2023-10-23

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

RecruitingNCT06283927

Jasper GerritsenAstrocytoma, Malignant, Astrocytoma of Brain, Glioblastoma +5

Start: 2023-01-01End: 2028-01-01Target: 464Updated: 2024-02-28

Related Papers

REMIT: Reirradiation of Diffuse Midline Glioma Patients -A Nordic Society of Paediatric Haematology and Oncology Feasibility Study.

2024-11-061 citations

Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors

Frontiers in Oncology2021-06-0811 citations

RBTT-09. A PHASE 1 STUDY OF CEMIPLIMAB IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY (R/R) SOLID AND CENTRAL NERVOUS SYSTEM (CNS) TUMORS

Neuro-Oncology2019-11-01